Skip to main content

Table 3 Pharmacological agents associated with 90-day mortality

From: Sedation practices and clinical outcomes in mechanically ventilated patients in a prospective multicenter cohort

Variable

Unadjusted model

p value

Adjusted model

p value

Age

1.62 (1.36–1.93)

< 0.001

1.34 (1.10–1.62)

< 0.001

Sex (males are reference)

0.94 (0.76–1.17)

0.59

0.93 (0.74–1.18)

0.55

APACHE III

2.24 (1.90–2.64)

< 0.001

2.17 (1.80–2.60)

< 0.001

Use of antipsychotics

0.31 (0.23–0.42)

< 0.001

0.31 (0.22–0.44)

< 0.001

Cumulative dose of benzodiazepines

1.07 (0.98–1.16)

0.12

1.41 (1.12–1.77)

< 0.01

Cumulative dose of opioids

1.01 (0.93–1.10)

0.77

0.82 (0.64–1.05)

0.12

Hospital site 1 (reference)

1.00

1.00

1.00

 

Hospital site 2

0.70 (0.52–0.96)

0.03

0.63 (0.45–0.89)

0.01

Hospital site 3

0.66 (0.47–0.93)

0.02

0.84 (0.58–1.22)

0.36

Hospital site 4

0.58 (0.43–0.78)

< 0.001

0.74 (0.54–1.01)

0.06

Hospital site 5

1.35 (0.89–2.06)

0.16

0.61 (0.38–0.99)

0.04